govardhanpillari
☆    

India,
2007-10-09 11:48
(6033 d 18:11 ago)

Posting: # 1165
Views: 4,801
 

 Designing & reporting of comparative BA [Study Per­for­mance]

Dear HS,

How would you conduct/assess Comparative bioavailability of 2 drug products of the same pharamacological category but of different molecules (that is test product is one of the isomer of reference product) and different strengths? Thanks.

regards,

Gov

Govardhan.P
Helmut
★★★
avatar
Homepage
Vienna, Austria,
2007-10-09 17:25
(6033 d 12:34 ago)

@ govardhanpillari
Posting: # 1167
Views: 3,833
 

 Designing & reporting of comparative BA

Dear Govardhan,

❝ (... test product is one of the isomer of reference product) and

❝ different strengths?


For example 20 mg Esomeprazole (the S-enantiomer) vs 40 mg Omeprazole (the 1:1 racemate)?

1. an enantioselective assay
2. demonstration of no interconversion S <-> R in vivo (possibly based on literature)
3. demonstration of no interconversion during sample preparation in your assay

Dif-tor heh smusma 🖖🏼 Довге життя Україна! [image]
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes
govardhanpillari
☆    

India,
2007-10-10 10:54
(6032 d 19:05 ago)

(edited by Jaime_R on 2007-10-10 14:08)
@ Helmut
Posting: # 1169
Views: 3,790
 

 Designing & reporting of comparative BA

Dear Helmut,

Thank u for reply. kindly give the complete details or where i can i get complete guidelines or information for this type of studies.

Regards,
goardhan.

--
Edit: Full quote removed. Please see this post! [Jaime]

Govardhan.P
UA Flag
Activity
 Admin contact
22,984 posts in 4,822 threads, 1,651 registered users;
38 visitors (0 registered, 38 guests [including 6 identified bots]).
Forum time: 05:59 CEST (Europe/Vienna)

You can’t fix by analysis
what you bungled by design.    Richard J. Light, Judith D. Singer, John B. Willett

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5